CHRISTINE DOWNEY: Open Payments
NPI 1851774707 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$874 in 35 payments from 14 companies in 2025. Trend: 2023 $487 · 2024 $335 · 2025 $874
Food & beverage: $874
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $203 |
| Amgen Inc. | 6 | $196 |
| Novartis Pharmaceuticals Corporation | 9 | $139 |
| ABBVIE INC. | 3 | $71 |
| CSL Behring | 3 | $52 |
| Teleflex LLC | 1 | $34 |
| Axsome Therapeutics, Inc. | 1 | $34 |
| Lilly USA, LLC | 1 | $25 |
| Novo Nordisk Inc | 1 | $23 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
Products named: BREZTRI, LEQVIO, REPATHA, Andembry, EVENITY, VRAYLAR, UROLIFT, Sunosi.
Industry payments across AZ — which companies pay providers there.
